Status:
COMPLETED
Evaluating the Efficacy of Pediatric Lipid Screening Alerts
Lead Sponsor:
Geisinger Clinic
Conditions:
Hypercholesterolemia
Hypercholesterolemia, Familial
Eligibility:
All Genders
9-11 years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate prospectively the impact of different system alerts on the prescription of lipid panels to pediatric Geisinger patients (9-11 years old), as per the now-univers...
Detailed Description
Patients who are eligible for this study will be randomized into one of four groups via an Epic electronic medical record (EMR) randomization algorithm run automatically at the time of the visit: 1. ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- male or female patients between the ages of 9 - 11
- seen within a primary care, cardiology, endocrinology, urgent care (CareWorks), or nutrition clinic at Geisinger
- Exclusion criteria:
- patients who have completed a lipid screen in the EMR
- patients who were determined to have familial hypercholesterolemia based on prior screening
Exclusion
Key Trial Info
Start Date :
October 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 11 2020
Estimated Enrollment :
13340 Patients enrolled
Trial Details
Trial ID
NCT04118348
Start Date
October 10 2019
End Date
October 11 2020
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Health System
Danville, Pennsylvania, United States, 17822